Last update :
28/02/2024
References   References 4709  
Type : Manufacturer

Research teams :
Authors :
Title : XERAVA® (eravacycline) for injection, for intravenous use. HIGHLIGHTS OF PRESCRIBING INFORMATION.
Reference : Tetraphase Pharmaceuticals. 2021

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionEravacycline Antibiotic
Factors which affect stability Temperature -20°C Induces Degradation
Stability in solutions Glass Water for Injection 10 mg/ml 25°C Not specified
1 Hour
Stability in solutions Glass Sodium chloride 0,9% 10 mg/ml 25°C Not specified
1 Hour
Stability in solutions Not specified Sodium chloride 0,9% 0,2 >>0,6 mg/ml 2-8°C Not specified
10 Day
Stability in solutions Not specified Sodium chloride 0,9% 0,2 >>0,6 mg/ml 25°C Not specified
24 Hour

  Mentions Légales